Plus Therapeutics, Inc.
PSTV
$0.5424
-$0.0855-13.62%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 275.20% | -433.61% | -2.44% | 10.72% | -98.38% |
| Total Depreciation and Amortization | -54.71% | -5.81% | 58.46% | 23.40% | -21.66% |
| Total Amortization of Deferred Charges | -- | -- | -100.00% | -100.00% | -92.45% |
| Total Other Non-Cash Items | -558.89% | 6,934.27% | -16.28% | -495.52% | -991.89% |
| Change in Net Operating Assets | -272.79% | 10.18% | 50.57% | -142.39% | 255.40% |
| Cash from Operations | -404.17% | -36.76% | 35.62% | -53.40% | 58.60% |
| Capital Expenditure | 91.36% | 92.50% | 73.81% | -40.00% | -636.36% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -24.29% | 1,189.81% | -- | -- | -- |
| Cash from Investing | -21.83% | 1,077.47% | 252.38% | 10.00% | -34,463.64% |
| Total Debt Issued | -100.00% | -- | -- | -- | -- |
| Total Debt Repaid | 100.00% | -1,640.05% | 100.00% | 100.00% | -794.03% |
| Issuance of Common Stock | -58.74% | -- | -100.00% | -100.00% | 436.32% |
| Repurchase of Common Stock | -- | -- | 100.00% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -388.89% | -- | -- | -- | -- |
| Cash from Financing | -59.84% | 1,698.58% | 100.00% | -100.00% | 624.56% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -479.61% | 273.20% | 53.22% | -3,423.42% | 210.01% |